Search hospitals
>
Michigan
>
Lansing
Sparrow Hospital
Claim this profile
Lansing, Michigan 48912
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Ovarian Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast cancer
371 reported clinical trials
10 medical researchers
Summary
Sparrow Hospital is a medical facility located in Lansing, Michigan. This center is recognized for care of Lung Cancer, Breast Cancer, Ovarian Cancer, Non-Small Cell Lung Cancer, Breast cancer and other specialties. Sparrow Hospital is involved with conducting 371 clinical trials across 492 conditions. There are 10 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.
Area of expertise
Lung Cancer
Sparrow Hospital has run 61 trials for Lung Cancer. Some of their research focus areas include:
Breast Cancer
Sparrow Hospital has run 45 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Tareq Al Baghdadi
Genesys Hurley Cancer Institute
9 years of reported clinical research
Christopher M. Reynolds, MD
Saint Joseph Mercy Hospital
3 years of reported clinical research
Philip J. Stella
Saint Joseph Mercy Hospital
5 years of reported clinical research
Elie G. Dib
Genesys Hurley Cancer Institute
7 years of reported clinical research
Clinical Trials running at Sparrow Hospital
Bladder Cancer
Lung Cancer
Prostate Cancer
Ovarian Cancer
Breast Cancer
Breast cancer
Multiple Myeloma
Kidney Cancer
Cancer
Esophageal cancer
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting
2 awards
Phase 3
Blood Test and Immunotherapy
for Bladder Cancer
This phase II/III trial examines whether patients who have undergone surgical removal of bladder, kidney, ureter or urethra, but require an additional treatment called immunotherapy to help prevent their urinary tract (urothelial) cancer from coming back, can be identified by a blood test. Many types of tumors tend to lose cells or release different types of cellular products including their DNA which is referred to as circulating tumor DNA (ctDNA) into the bloodstream before changes can be seen on scans. Health care providers can measure the level of ctDNA in blood or other bodily fluids to determine which patients are at higher risk for disease progression or relapse. In this study, a blood test is used to measure ctDNA and see if there is still cancer somewhere in the body after surgery and if giving a treatment will help eliminate the cancer. Immunotherapy with monoclonal antibodies, such as nivolumab and relatlimab, can help the body's immune system to attack the cancer, and can interfere with the ability of tumor cells to grow and spread. This trial may help doctors determine if ctDNA measurement in blood can better identify patients that need additional treatment, if treatment with nivolumab prolongs patients' life and whether the additional immunotherapy treatment with relatlimab extends time without disease progression or prolongs life of urothelial cancer patients who have undergone surgical removal of their bladder, kidney, ureter or urethra.
Recruiting
1 award
Phase 2 & 3
10 criteria
Gemcitabine + Cisplatin
for Bladder Cancer
This phase II trial studies how well gemcitabine hydrochloride and cisplatin work in treating participants with invasive bladder urothelial cancer. Drugs used in chemotherapy, such as gemcitabine hydrochloride and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
Recruiting
1 award
Phase 2
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Sparrow Hospital?
Sparrow Hospital is a medical facility located in Lansing, Michigan. This center is recognized for care of Lung Cancer, Breast Cancer, Ovarian Cancer, Non-Small Cell Lung Cancer, Breast cancer and other specialties. Sparrow Hospital is involved with conducting 371 clinical trials across 492 conditions. There are 10 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.
Where is Sparrow Hospital located?
**Directions to Sparrow Hospital, Lansing, Michigan:** - From I-496 W, take exit 7 for US-127 N towards East Lansing. - Merge onto US-127 N using the left lane and continue for 2 miles. - Take exit 9 for Trowbridge Rd, turn right onto E Michigan Ave, and the hospital will be on your left after 0.5 miles.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Sparrow Hospital, please contact the following: - Financial Assistance and Sparrow Health System Inquiries: 517.364.8432 or toll-free at 877.275.0076. - Insurance-Related Inquiries: 517.364.8456. Sparrow Health System offers financial assistance to eligible patients, determined by family size and household income.
What insurance does Sparrow Hospital accept?
Sparrow Hospital, part of the MyMichigan Health network, accepts a wide range of insurance plans, including but not limited to Aetna, Blue Care Network, Blue Cross Blue Shield of Michigan, Cigna-Priority Health Strategic Alliance, and United Health Care. It is important to verify with your provider's office about their participation in your insurance plan before scheduling an appointment. Sparrow Health System also offers comprehensive benefits for its employees, encompassing health, dental, and vision options, income protection, retirement savings plans, and more.
What awards or recognition has Sparrow Hospital received?
Sparrow Hospital, located in Lansing, Michigan, is renowned for its significant contributions to health disparities research, earning a national quality improvement award in 2017. Furthermore, Sparrow Health System has been honored with 10 awards by Professional Research Consultants, Inc. for exceptional patient satisfaction, underscoring its dedication to delivering high-quality care.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.